Mayo scientists researching ‘beyond DNA’ to advance personalized medicine – Mayo Clinic News Network

As the country marks National DNA Day on Sunday, April 25 — a working day that commemorates the discovery of DNA’s double helix in 1953 and the completion of the Human Genome Project in 2003 — Mayo Clinic physicians and researchers will continue to closely collaborate to press the boundaries of precision drugs in the areas of cancer, uncommon and undiagnosed ailments, and predictive genomics.

Mayo Clinic has put in decades checking out and sequencing the human genome, permitting doctors to tailor a selection of therapies to a patient’s genes. Now scientists in Mayo Clinic’s Heart for Individualized Medication will continue on taking the achievement a stage even further ― outside of DNA ― and focusing on “multi-omics” knowledge in their search for responses, such as proteomics, the analyze of proteins in a mobile microbiome, the research of microorganisms, fungi, protozoa and viruses that are living inside of the physique and metabolomics, the review of chemical processes to discover the fundamental will cause of health conditions.

We requested five scientists in just the Centre for Individualized Medicine to replicate on the landmark achievements of DNA discovery and how it has impacted their investigation and skill to precisely diagnose, address and predict disease for sufferers.

Read through the relaxation of the short article on the Heart for Individualized Medication web site.

____________________________________________

Other Mayo Clinic health-related study web sites: